SOLL DAVID B has a total of 14 patent applications. Its first patent ever was published in 1981. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and basic materials chemistry are JRX BIOTECHNOLOGY INC, NEWLENS LLC and PITMY INTERNAT N V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Basic materials chemistry | |
#4 | Micro-structure and nano-technology | |
#5 | Optics | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Diagnosis and surgery | |
#5 | Preservation of human bodies | |
#6 | Nanostructure applications | |
#7 | Unspecified technologies | |
#8 | Cameras |
# | Name | Total Patents |
---|---|---|
#1 | Soll David B | 14 |
#2 | Harrison Sol E | 4 |
#3 | Failla Stephen J | 2 |
#4 | Feinbloom Richard E | 1 |
Publication | Filing date | Title |
---|---|---|
US2012134662A1 | Viewfinder | |
US2010105643A1 | Ophthalmic composition | |
WO2007047242A2 | Ophthalmic surgical irrigating solutions containing hyaluronidase | |
TW200719827A | Composition and method for in vitro preservation of corneal tissues | |
US6969514B2 | Method for treating elevated intraocular pressure, including glaucoma | |
US5166048A | Protection of human corneal endothelial cells | |
US5006123A | Sclera and/or limbus marking device for use in intraocular surgery | |
US4880017A | Method of marking the sclera and/or limbus in intraocular surgery | |
US4971955A | Protection of human and animal cells during surgical trauma | |
CA1187798A | Protection of cells | |
US4486416A | Protection of human and animal cells subject to exposure to trauma |